<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[GHO Capital Partners LLP 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=34351></link><description><![CDATA[GHO Capital Partners LLP 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Sat, 16 May 2026 11:12:16 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><image><url><![CDATA[https://file.newswire.co.kr/data/upfile/company_img/2020/01/12_3554238800_20200110173751_5070462695.jpg]]></url></image><language>ko-KR</language><item><title><![CDATA[GHO 캐피털, 중소 바이오제약 회사들을 대상으로 한 조기 단계 신약개발 및 제조 CDMO 전문 회사인 아데나를 인수]]></title><link>https://www.newswire.co.kr/newsRead.php?no=899910</link><description><![CDATA[런던--(Business Wire/뉴스와이어)--유럽의 건강관리 분야 전문 투자회사인 글로벌 헬스케어 오퍼튜니티(Global Healthcare Opportunities) 또는 GHO 캐피털 파트너스(GHO Capital Partners LLP)가 기존의 경영팀과 함께 초기 단계 신약개발에 초점을 맞추는 위탁개발·생산 조직(CDMO) 아데나(Ardena)를 멘타 캐피털(Mentha Capital)로부터 인수했다.  아데나는 멀티서비스 CDMO 회사로서 제품수명주기 처음부...]]></description><pubDate>Fri, 10 Jan 2020 17:51:44 +0900</pubDate></item><item><title><![CDATA[GHO Capital Acquires Ardena, a Leading CDMO Providing Early Stage Drug Development and Manufacturing for Small-to-mid Sized Biopharma]]></title><link>https://www.newswire.co.kr/newsRead.php?no=899909</link><description><![CDATA[LONDON--(Business Wire/Korea Newswire)--Global Healthcare Opportunities, or GHO Capital Partners LLP, the European specialist investor in healthcare, together with the existing management team has acquired Ardena, a specialist contract development and manufacturing organization (CDMO) focused on early phase drug development, from Mentha Capital.  Ardena is a multi-service CDMO, assist...]]></description><pubDate>Fri, 10 Jan 2020 17:40:05 +0900</pubDate></item></channel></rss>